Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company’s stock gained early Tuesday immediately after the announcement.
Worldwide sales edged up 1% year-over-year to $12.55 billion and far exceeded expectations. Excluding foreign exchange impacts, sales grew 2%. The top-line benefitted from strength in the oncology and human health vaccines.
Net earnings, on an adjusted basis, rose to $1.74 per share from $1.51 per share in the third quarter of 2019 and surpassed the market’s forecast.
Unadjusted net income advanced to $2.94 billion or $1.16 per share from $1.90 billion or $0.74 per share last year.
Read management/analysts’ comments on Merck’s Q3 2020 earnings
Shares of the company gained during Tuesday’s premarket trading, after closing the previous session lower.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results
Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
